Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial

Por Mathews, Maju, Gommoll, Carl, Chen, Dalei, Nunez, Rene, Khan, Arif
Publicado no Int Clin Psychopharmacol (2015)

Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: post-hoc analyses of a phase IV trial

Por Citrome, Leslie, Gommoll, Carl P., Tang, Xiongwen, Nunez, Rene, Mathews, Maju
Publicado no Int Clin Psychopharmacol (2015)

Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial

Por Clayton, Anita H., Gommoll, Carl, Chen, Dalei, Nunez, Rene, Mathews, Maju
Publicado no Int Clin Psychopharmacol (2015)

Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study

Por Gommoll, Carl, Forero, Giovanna, Mathews, Maju, Nunez, Rene, Tang, Xiongwen, Durgam, Suresh, Sambunaris, Angelo
Publicado no Int Clin Psychopharmacol (2015)

A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, FIXED-DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER

Por Gommoll, Carl, Durgam, Suresh, Mathews, Maju, Forero, Giovanna, Nunez, Rene, Tang, Xiongwen, Thase, Michael E
Publicado no Depress Anxiety (2015)

Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study

Por Bakish, David, Bose, Anjana, Gommoll, Carl, Chen, Changzheng, Nunez, Rene, Greenberg, William M., Liebowitz, Michael, Khan, Arif
Publicado em 2014

Serie estudios en ciencias penales y derechos humanos : en homenaje a Antonio Sánchez Galindo /

Por Leal, César Barros, Murillo De la Rosa, Mauricio Alejandro, Yebra Núnez, René, Instituto Estatal de Ciencias Penales., Instituto Brasileiro de Direitos Humanos., Congreso del Estado de Guanajuato.
Publicado em 2010